证券之星消息，11月21日医疗器械板块较上一交易日下跌2.09%，济高发展领跌。当日上证指数报收于 3834.89，下跌2.45%。深证成指报收于12538.07，下跌3.41%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 301367 | 瑞迈特 | 95.38 | 3.43% | 3.51万 | | 3.36亿 | | 688271 | 联影医疗 | 133.50 | 2.15% | 6.15万 | | 8.19亿 | | 688656 | 浩欧博 | 174.88 | 1.00% | 0 1.27万 | | 2.28亿 | | 603658 | 安图生物 | 37.03 | 0.43% | - 3.34万 | | 1.23亿 | | 920925 | 锦好医疗 | 31.73 | -0.19% | 1.02万 | | 3126.12万 | | 688114 | 华大智造 | 60.89 | -0.25% | 3.27万 | | 286T | ...

证券代码：600807 证券简称：济高发展 公告编号：临 2025-061 济南高新发展股份有限公司 2025年第四次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 11 月 18 日 (二)股东会召开的地点：中国（山东）自由贸易试验区济南片区经十东路 7000 号汉峪金融商务中心 A4-4 号楼 1123 会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 198 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 43,816,011 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 5.0353 | (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次会议由公司董事会召集，公司过半数董事推举董事雷学锋先生主持本次 会议，会议 ...

关 于 济 南 高 新 发 展 股 份 有 限 公 司 2025 年 第 四 次 临 时 股 东 会 的 法 律 意 见 书 北 京 大 成 （ 济 南 ） 律 师 事 务 所 www.dentons.cn BEIJINGDENTONSLAWOFFICES,LLP(JINAN) 济南市历下区龙奥北路 8 号玉兰广场 4 号楼 7-8 层(250101) 7-8/F,Building4,YulanPlaza,No.8LongAoNorthRoad,LixiaDistrict,250101,Jinan,China Tel：+86531-88878388Fax：+86531-88726767 北京大成（济南）律师事务所 关于济南高新发展股份有限公司 2025 年第四次临时股东会的法律意见书 致：济南高新发展股份有限公司 （一）本次股东会的召集程序 本次股东会由董事会提议并召集。2025 年 10 月 30 日，公司召开第十一届 董事会第二十七次临时会议，审议通过《关于审议召开 2025 年第四次临时股东 会的议案》。 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民 共和国公司法》（以下简称"《公 ...

Market Performance - On November 13, the Shandong state-owned enterprise reform sector rose by 1.17%, with Furi Shares leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Top Gainers in Shandong State-Owned Enterprises - Key stocks in the Shandong state-owned enterprise reform sector included: - Qirui Shares (002083) closed at 10.51, up 10.05% with a trading volume of 182,000 shares and a turnover of 191 million yuan [1] - Shida Shenghua (603026) closed at 91.38, up 10.00% with a trading volume of 72,400 shares and a turnover of 655 million yuan [1] - Jiga Development (600807) closed at 3.88, up 9.92% with a trading volume of 561,900 shares and a turnover of 216 million yuan [1] Market Capital Flow - The Shandong state-owned enterprise reform sector experienced a net outflow of 132 million yuan from institutional investors, while retail investors saw a net inflow of 138 million yuan [2] - The top stocks by net inflow from retail investors included: - Qirui Shares (002083) with a net inflow of 64.38 million yuan, accounting for 33.65% of its trading volume [3] - ST Chenming (000488) with a net inflow of 38.29 million yuan, accounting for 29.70% of its trading volume [3] Notable Decliners - Some stocks in the sector faced declines, including: - Shandong High-speed (600350) closed at 9.37, down 1.99% with a trading volume of 97,100 shares and a turnover of 9.13 million yuan [2] - Shandong High-tech (000803) closed at 8.50, down 2.52% with a trading volume of 1,180,500 shares and a turnover of 1.06 billion yuan [2]

Market Overview - The medical device sector experienced a slight increase of 0.04% on November 13, with Hotgen Biotech leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Top Gainers - Hotgen Biotech (688068) closed at 170.15, with a significant increase of 11.36% and a trading volume of 59,400 shares [1] - Jikang Development (600807) saw a rise of 9.92%, closing at 3.88 with a trading volume of 561,900 shares [1] - Hualan Biological Engineering (301093) increased by 8.35%, closing at 49.55 with a trading volume of 77,300 shares [1] - Other notable gainers include Baijun Medical (688198) up 6.14% and Wuzhou Medical (301234) up 4.43% [1] Top Losers - Yuanpeng Medical (300753) experienced a decline of 6.35%, closing at 28.76 with a trading volume of 150,800 shares [2] - Zhend Medical (603301) fell by 2.93%, closing at 88.04 with a trading volume of 82,900 shares [2] - Other significant declines include Kefu Medical (301087) down 2.73% and Canar Co. (301122) down 2.71% [2] Capital Flow - The medical device sector saw a net outflow of 937 million yuan from institutional investors, while retail investors contributed a net inflow of 722 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors remain active [2] Individual Stock Capital Flow - Jikang Development had a net inflow of 47.75 million yuan from institutional investors, while retail investors showed a net outflow of 36.24 million yuan [3] - Hualan Biological Engineering recorded a net inflow of 44.30 million yuan from institutional investors, with retail investors experiencing a net outflow of 47.73 million yuan [3] - Other stocks like Sanxin Medical (300453) and Wuzhou Medical (301234) also showed varied capital flows, reflecting differing investor sentiments [3]

济南高新发展股份有限公司 二〇二五年第四次临时股东会 会 议 资 料 二〇二五年十一月 济高发展（600807） 2025 年第四次临时股东会 2025年第四次临时股东会会议议程 现场会议召开时间：2025年11月18日 上午9点15分； 网络投票时间：采用上海证券交易所股东会网络投票系统，通过交易系统投 票平台的投票时间为股东会召开当日的交易时间段，即9:15—9:25,9:30— 11:30，13:00—15:00；通过互联网投票平台的投票时间为股东会召开当日 9:15-15:00。 一、主持人宣布代表资格审查结果； 二、宣读"会议须知"； 三、审议并讨论议案： 1、关于全资子公司签署相关资产运营委托协议暨关联交易的议案； 2、关于控股子公司签署相关物业服务委托合同暨关联交易的议案。 四、股东或股东授权代表投票表决： 1、推举监票人； 2、投票表决。 现场会议地点：中国（山东）自由贸易试验区济南片区经十东路7000号汉峪 金融商务中心A4-4号楼11层1123室 会议召集人：公司董事会 会议议程： 五、计票； 六、主持人宣布股东会现场部分结束。 1 济高发展（600807） 2025 年第四次临时股东会 ...

Core Viewpoint - The medical device sector experienced a slight decline of 0.31% on November 6, with Danaher Biomedical leading the losses, while the overall market indices showed gains, with the Shanghai Composite Index up by 0.97% and the Shenzhen Component Index up by 1.73% [1][2]. Group 1: Market Performance - The Shanghai Composite Index closed at 4007.76, increasing by 0.97% [1]. - The Shenzhen Component Index closed at 13452.42, increasing by 1.73% [1]. - The medical device sector saw a net outflow of 638 million yuan from major funds, while retail investors contributed a net inflow of 446 million yuan [2][3]. Group 2: Individual Stock Performance - Hualan Co., Ltd. (301093) saw a significant increase of 8.53%, closing at 44.00 yuan with a trading volume of 67,500 shares and a transaction value of 293 million yuan [1]. - Danaher Biomedical (920009) led the declines with a drop of 4.69%, closing at 83.50 yuan and a trading volume of 24,900 shares, resulting in a transaction value of 206 million yuan [2]. - Other notable gainers included Furuida (300049) with a 4.32% increase and a closing price of 74.56 yuan, and Kangzhong Medical (688607) with a 3.04% increase, closing at 29.81 yuan [1][2]. Group 3: Fund Flow Analysis - Major funds showed a net outflow in several stocks, including Furuida with a net outflow of 23.99 million yuan, while retail investors showed a net inflow of 25.27 million yuan [3]. - Dongfulong (300171) experienced a net inflow of 21.17 million yuan from major funds, indicating positive sentiment towards the stock [3]. - The overall trend indicates a mixed sentiment in the medical device sector, with some stocks attracting retail interest despite the overall outflow from major funds [2][3].

Group 1 - The core point of the article highlights that Jihigh Development (SH 600807) reported a significant decline in its financial performance for the first three quarters of 2025, with revenue of approximately 222 million yuan, representing a year-on-year decrease of 17.59% [1] - The company experienced a net loss attributable to shareholders of approximately 82.05 million yuan, indicating financial struggles [1] - Basic earnings per share for the company were reported as a loss of 0.09 yuan, reflecting the overall negative financial trend [1] Group 2 - The article also discusses the phenomenon of "negative electricity prices" in multiple regions, questioning why power plants are reluctant to shut down despite not making profits from electricity sales [1]

Group 1 - The company reported a total operating revenue of 222,234,436.32 yuan for the first three quarters, representing a year-on-year decrease of 17.59% [1] - The net profit attributable to shareholders of the listed company was -82,052,940.44 yuan [1] Group 2 - Among the top ten circulating shareholders, Tang Jianbai is a newly added circulating shareholder [2]

Core Insights - The company reported a revenue of 63.26 million yuan for Q3 2025, reflecting a year-on-year increase of 1.64% [1] - The net profit attributable to shareholders was -35.38 million yuan, indicating a loss [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -15.70 million yuan [1]